INDIA LIVE DESKNIFTY 50:23,140.50(+0.34%)SENSEX:73,895.74(+0.43%)
RDU Global
🇮🇳
🇮🇳 India Edition • Macro Economy & Fiscal PolicyRDU GLOBAL CORRESPONDENT
VERIFIED WIRE INTELLIGENCE

"Motilal Oswal Sees Aster DM EBITDA Rising 25% CAGR Through FY28, Sets Rs 910 Target"

Motilal Oswal has initiated coverage on Aster DM Quality Care with a Buy rating and a target price of Rs 910, arguing that the healthcare provider is entering a stronger growth phase supported by merger synergies, capacity expansion and improving operating performance. The brokerage expects revenue, EBITDA and PAT to compound at 19.5%, 25% and 33%, respectively, through FY28, signalling confidence in both scale and margin expansion.

Motilal Oswal Sees Aster DM EBITDA Rising 25% CAGR Through FY28, Sets Rs 910 Target

R

RDU Global Wire

Macro Economy & Fiscal Policy Desk

New Delhi, India Just now (10:42 AM IST)•5 min read

Motilal Oswal has initiated coverage on Aster DM Quality Care with a Buy rating and a target price of Rs 910, arguing that the healthcare provider is entering a stronger growth phase supported by merger synergies, capacity expansion and improving operating performance. The brokerage expects revenue, EBITDA and PAT to compound at 19.5%, 25% and 33%, respectively, through FY28, signalling confidence in both scale and margin expansion.

Motilal Oswal has initiated coverage on Aster DM Quality Care with a Buy rating and a target price of Rs 910, arguing that the healthcare provider is entering a stronger growth phase supported by merger synergies, capacity expansion and improving operating performance. The brokerage expects revenue, EBITDA and PAT to compound at 19.5%, 25% and 33%, respectively, through FY28, signalling confidence in both scale and margin expansion.

Editorial & Verification Notice

Reported by RDU Global Correspondent. Formatted and verified using real-time institutional and journalistic wire feeds. Independent reporting adhering to the RDU Global Editorial Code of Conduct.

Related Coverage